Medcura develops biopolymer-based hemostatic technologies and surgical bleeding-control products, centered on a proprietary hydrophobically modified chitosan platform. Its flagship LifeGel flowable gel received FDA Breakthrough Device Designation in 2022 for procedures where swelling cannot be tolerated, while the company’s scientists and engineers continue developing the platform in formats such as films, powders and gauze. Based in Riverdale, Maryland, Medcura works with surgeons and healthcare professionals throughout product development.
FDA Breakthrough Device Designation
Compliance program
FDA Clearance K143466
Registration
FDA Clearance K172010
Registration
FDA Clearance K180152
Registration
FDA Clearance K182811
Registration
FDA Clearance K192667
Registration
Omni-stat Medical IncEstablished in 2018, Omni-stat Medical develops temporary topical hemostats for controlling bleeding in hospital and emergency-care settings. Its OMNI-STAT and CELOX products use proprietary chitosan granule technology, developed for wounds ranging from minor bleeding to severe arterial injuries and shown to work in the presence of common anticoagulants. The New York-based company is a subsidiary of Medtrade Products Limited and provides product training alongside its clinical solutions.New York, NY
CoagCo LLCCoagCo LLC develops bleeding-control medical devices, including the Coag it NP7 sterile nasal packing device for treating nosebleeds. Cleveland-based and co-founded by ENT physician Jeffrey E. Binder and attorney Tim Clements III, the company focuses on products that can help nurses, first responders, military medics and other providers control blood loss quickly. Its NP7 is made in America and designed for atraumatic insertion without local anesthesia.CLEVELAND, OH
BC3 TechnologiesFounded in Baltimore in 2018, minority-owned BC3 Technologies develops and manufactures emergency bleeding-control products, including its FDA-cleared SEAL Hemostatic Wound Spray. The company makes and distributes its products in Maryland, drawing on a leadership team with 35 years of medical-device and drug-manufacturing experience and deep backgrounds in chemistry and emergency care.BALTIMORE, MD
Aleo BME, IncFounded by scientists from Pennsylvania State University, State College-based Aleo BME develops and manufactures polymeric biomaterials for medical applications. Its nature-inspired polymer platform has produced ElaSkin® Liquid Bandage, an FDA-cleared product made at the company’s cGMP-compliant Pennsylvania facility, while its research pipeline extends into surgical adhesives and tissue repair.541714STATE COLLEGE, PA